Related Experiment Video
Updated: Mar 27, 2026

Isolation and Identification of Extravascular Immune Cells of the Heart
Published on: August 23, 2018
[Inflammatory heart diseases--cardiac sarcoidosis and giant cell myocarditis]
Insights
Cardiac sarcoidosis and giant cell myocarditis share symptoms like heart block and insufficiency. Improved diagnostics are increasing diagnoses for these inflammatory heart diseases.
Area of Science:
- Cardiology
- Immunology
- Pathology
Context:
- Cardiac sarcoidosis and giant cell myocarditis are rare but serious inflammatory heart conditions.
- Symptoms include atrioventricular block, ventricular tachycardia, and cardiac insufficiency.
- Diagnosis relies on imaging (cardiac MRI, PET) and definitive histologic examination of cardiac tissue.
Purpose:
- To summarize the key aspects of cardiac sarcoidosis and giant cell myocarditis.
- To highlight diagnostic approaches and treatment strategies.
- To underscore the increasing incidence and challenges in managing these diseases.
Summary:
- Both conditions present with similar cardiac symptoms, necessitating advanced diagnostic tools like cardiac MRI and PET scans.
- Histologic examination remains the gold standard for diagnosis.
- While corticosteroids manage sarcoidosis, giant cell myocarditis requires more aggressive immunosuppression, with a significant portion needing heart transplantation.
Impact:
- Increased diagnostic capabilities are leading to earlier identification of these inflammatory heart diseases.
- Understanding treatment differences is crucial for patient outcomes.
- Giant cell myocarditis poses a higher short-term mortality risk, often necessitating heart transplantation.
Abstract:
The most common symptoms of cardiac sarcoidosis and giant cell myocarditis are atrioventricular block, ventricular tachycardia and cardiac insufficiency. Magnetic resonance imaging of the heart or positron emission tomography are utilized to evaluate the possibility of inflammatory heart disease. The diagnosis is based on histologic examination of a cardiac muscle tissue specimen. For both diseases, the increase in the number of diagnoses is likely to be due to improved diagnostics. The cause of cardiac sarcoidosis is not known, but granulomatous inflammation can be suppressed with corticosteroids. In giant cell myocarditis, more powerful immunosuppression is utilized than in sarcoidosis, but one third of the patients still require heart transplantation within one year from the diagnosis.
More Related Videos
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
10:21Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Myocarditis I: Introduction
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests